Tissue expression
Cell line expression

BTNL2

gene product
BTL-II, BTN7, HSBLMHC1 
This gene encodes a major histocompatibility complex, class II associated, type I transmembrane protein which belongs to the butyrophilin-like B7 family of immunoregulators. It is thought to be involved in immune surveillance, serving as a negative T-cell regulator by decreasing T-cell proliferation and cytokine release. The encoded protein contains an N-terminal signal peptide, two pairs of immunoglobulin-like domains, separated by a heptad peptide sequence, and a C-terminal transmembrane domain. Naturally occurring mutations in this gene are associated with sarcoidosis, rheumatoid arthritis, ulcerative colitis, inflammatory bowel disease, myositis, type 1 diabetes, systemic lupus erythematosus, acute coronary syndrome, and prostate cancer. [provided by RefSeq, May 2017]
More gene data

Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Antigen sequence

Conjugate

Epitope

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
139 antibodies from 19 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Cusabio Biotech Co., Ltd
5 antibodies
Invitrogen Antibodies
6 antibodies
LifeSpan BioSciences, Inc.
10 antibodies
Biorbyt
13 antibodies
Proteintech Group
1 antibody
Bioworld Technology, Inc
1 antibody
NovoPro Bioscience Inc.
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
antibodies-online
47 antibodies
Abnova Corporation
1 antibody
GeneTex
1 antibody
Novus Biologicals
1 antibody
R&D Systems
1 antibody
St John's Laboratory
2 antibodies
Creative Diagnostics
18 antibodies
Creative Biolabs
11 antibodies
Abbexa
6 antibodies
MyBioSource
1 antibody